Education
About Us
Working with TipRanks
Follow Us
Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826)
:6826
Total Valuation
Shanghai Haohai Biological Technology Co., Ltd. Class H has a market cap or net worth of HK$11.00B. The enterprise value is HK$6.73B.
Market CapHK$11.00B
Enterprise ValueHK$6.73B
Share Statistics
Shanghai Haohai Biological Technology Co., Ltd. Class H has 36,509,740 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding36,509,740
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shanghai Haohai Biological Technology Co., Ltd. Class H’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 4.28%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)4.28%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee1.24M
Profits Per Employee216.21K
Employee Count2,156
Asset Turnover0.38
Inventory Turnover1.65
Valuation Ratios
The current PE Ratio of Shanghai Haohai Biological Technology Co., Ltd. Class H is 14.5. Shanghai Haohai Biological Technology Co., Ltd. Class H’s PEG ratio is -0.53.
PE Ratio14.5
PS Ratio2.18
PB Ratio1.05
Price to Fair Value1.05
Price to FCF20.61
Price to Operating Cash Flow16.47
PEG Ratio-0.53
Income Statement
In the last 12 months, Shanghai Haohai Biological Technology Co., Ltd. Class H had revenue of 2.68B and earned 420.45M in profits. Earnings per share was 1.80.
Revenue2.68B
Gross Profit1.87B
Operating Income347.93M
Pretax Income466.14M
Net Income420.45M
EBITDA549.05M
Earnings Per Share (EPS)1.80
Cash Flow
In the last 12 months, operating cash flow was 633.75M and capital expenditures -220.59M, giving a free cash flow of 413.50M billion.
Operating Cash Flow633.75M
Free Cash Flow413.50M
Free Cash Flow per Share11.33
Dividends & Yields
Shanghai Haohai Biological Technology Co., Ltd. Class H pays an annual dividend of HK$0.438, resulting in a dividend yield of 4.28%
Dividend Per ShareHK$0.438
Dividend Yield4.28%
Payout Ratio48.40%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.85
52-Week Price Change12.65%
50-Day Moving Average26.19
200-Day Moving Average26.29
Relative Strength Index (RSI)54.37
Average Volume (3m)211.55K
Important Dates
Shanghai Haohai Biological Technology Co., Ltd. Class H upcoming earnings date is Mar 21, 2026, TBA (Confirmed).
Last Earnings DateOct 24, 2025
Next Earnings DateMar 21, 2026
Ex-Dividend Date―
Financial Position
Shanghai Haohai Biological Technology Co., Ltd. Class H as a current ratio of 4.22, with Debt / Equity ratio of 7.35%
Current Ratio4.22
Quick Ratio3.66
Debt to Market Cap0.07
Net Debt to EBITDA-3.97
Interest Coverage Ratio19.26
Taxes
In the past 12 months, Shanghai Haohai Biological Technology Co., Ltd. Class H has paid 89.90M in taxes.
Income Tax89.90M
Effective Tax Rate0.19
Enterprise Valuation
Shanghai Haohai Biological Technology Co., Ltd. Class H EV to EBITDA ratio is 6.65, with an EV/FCF ratio of 12.91.
EV to Sales1.36
EV to EBITDA6.65
EV to Free Cash Flow12.91
EV to Operating Cash Flow5.63
Balance Sheet
Shanghai Haohai Biological Technology Co., Ltd. Class H has HK$2.60B in cash and marketable securities with HK$412.87M in debt, giving a net cash position of HK$2.19B billion.
Cash & Marketable SecuritiesHK$2.60B
Total DebtHK$412.87M
Net CashHK$2.19B
Net Cash Per ShareHK$59.88
Tangible Book Value Per ShareHK$20.54
Margins
Gross margin is 67.59%, with operating margin of 12.98%, and net profit margin of 15.69%.
Gross Margin67.59%
Operating Margin12.98%
Pretax Margin17.40%
Net Profit Margin15.69%
EBITDA Margin20.49%
EBIT Margin13.88%
Analyst Forecast
The average price target for Shanghai Haohai Biological Technology Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-8.49%
EPS Growth Forecast-9.46%